Suchergebnisse - "Fernández, M A"

PubPharm (868)

1

Making an accurate diagnosis of anterior mediastinal lesions : a proposal for a new diagnostic algorithm from the BTOG Thymic Malignancies Special Interest Group

enthalten in: Clinical radiology | 2024

von Evison, M. | Robinson, S. | Sharman, A. | +6

2

Incorporation of patient-reported outcomes into pharmacy and dermatology departments, in psoriasis and atopic dermatitis patients, as a tool to improve the healthcare quality and health outcomes

enthalten in: Journal of healthcare quality research | 2024

von González-Fernández, M. | Herranz-Pinto, P. | Alonso-Pacheco, M. | +5

3

Critical overview on the use of hydrophobic (deep) eutectic solvents for the extraction of organic pollutants in complex matrices

enthalten in: Talanta | 2024

von Bintanel-Cenis, J. | Fernández, M. | Gómara, B. | +1

4

Immune modulation via dendritic cells by the effect of Thymosin-alpha-1 on immune synapse in HCMV infection

enthalten in: International immunopharmacology | 2023

von Espinar-Buitrago, M. | Vazquez-Alejo, E. | Magro-Lopez, E. | +3

5

Recommendations for thromboembolic disease in oncological processes. A view from primary care

enthalten in: Semergen | 2023

von García Vallejo, O. | Aicart Bort, M. | Babiano Fernández, M. | +7

6

The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2

enthalten in: Immunity & ageing : I & A | 2023

von Espinar-Buitrago, M. | Tarancon-Diez, L. | Vazquez-Alejo, E. | +5

7

The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2

enthalten in: Immunity & ageing | 2023

von Espinar-Buitrago, M. | Tarancon-Diez, L. | Vazquez-Alejo, E. | +5

8

The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2

enthalten in: Immunity & ageing | 2023

von Espinar-Buitrago, M. | Tarancon-Diez, L. | Vazquez-Alejo, E. | +5

9

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

enthalten in: EClinicalMedicine | 2023

von Compagnucci, A. | Chan, M. | Saïdi, Y. | +131

10

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older : a PK substudy of the SMILE trial

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Abdalla, S. | Compagnucci, A. | Zheng, Y. | +39

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[87]